VSTM (STOCKS)
Verastem, Inc.
$6.670000
-0.280000 (-4.03%)
Prev close: $6.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Daniel W. Paterson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $736.72M
- Employees
- 78
- P/E (TTM)
- -2.83
- P/B (TTM)
- 12.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.35 | $-0.44 | +0.0913 | +20.69% |
|
Mar 2026 (Q1)
|
$-0.46 | $-0.47 | +0.0103 | +2.19% |
|
Dec 2025 (Q4)
|
$-0.50 | $-0.55 | +0.0542 | +9.78% |
|
Sep 2025 (Q3)
|
$-1.35 | $-0.65 | -0.7016 | -108.20% |
Financial Statements
| Revenues | $87.53M |
| Benefits Costs and Expenses | $231.61M |
| Costs And Expenses | $247.32M |
| Operating Expenses | $247.32M |
| Selling, General, and Administrative Expenses | $95.16M |
| Research and Development | $140.22M |
| Other Operating Expenses | $11.94M |
| Operating Income/Loss | -$159.80M |
| Income/Loss From Continuing Operations After Tax | -$202.70M |
| Income/Loss From Continuing Operations Before Tax | -$144.08M |
| Interest Expense, Operating | $1.48M |
| Net Income/Loss | -$202.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$202.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$202.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.36 |
| Diluted Earnings Per Share | -$2.45 |
| Basic Average Shares | 177,114,000 |
| Diluted Average Shares | 177,539,000 |
| Assets | $206.51M |
| Current Assets | $176.16M |
| Cash | $136.40M |
| Inventory | $2.40M |
| Other Current Assets | $37.36M |
| Noncurrent Assets | $30.36M |
| Liabilities | $156.53M |
| Current Liabilities | $78.13M |
| Accounts Payable | $18.00M |
| Wages | $6.64M |
| Other Current Liabilities | $53.50M |
| Noncurrent Liabilities | $78.40M |
| Equity | $49.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $49.99M |
| Liabilities And Equity | $206.51M |
| Net Cash Flow From Operating Activities | -$162.20M |
| Net Cash Flow From Operating Activities, Continuing | -$162.20M |
| Net Cash Flow From Investing Activities | $66.12M |
| Net Cash Flow From Investing Activities, Continuing | $66.12M |
| Net Cash Flow From Financing Activities | $143.62M |
| Net Cash Flow From Financing Activities, Continuing | $143.62M |
| Net Cash Flow | $47.54M |
| Net Cash Flow, Continuing | $47.54M |
| Comprehensive Income/Loss | -$189.37M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$189.37M |
| Other Comprehensive Income/Loss | -$85.19M |